Skip to main content
GameRevenueData

Publisher

Games Published by WASABI entertainment: Revenue & Sales Estimates

Revenue estimates for the 60 Steam games published by WASABI entertainment, ranked by estimated net revenue. Available estimated lifetime net (USD): $907.1K. Page 2 of 2.

Coverage: 60 tracked titles; 57 with net estimates; 3 without. 2 have dedicated profiles. Missing estimates are excluded from the aggregate, not treated as known zero revenue.

Role: Publisher. These are lifetime estimates for games credited to WASABI entertainment; they are not company earnings, profit, or contractual receipts. Credits may omit co-development or historical publishing arrangements. Developer and publisher identities are not merged by matching names.

Recorded release dates: 2020-08-10–2025-09-07 (may include announced dates).

Largest title accounts for 37.4% of available estimated net revenue. Coverage gaps can change this share.

Showing 51–60 of the top 60 displayed entries, from 60 tracked titles. Figures include only available estimates. Search the full catalog .

Rows 51–60 · Page 2 of 2

# Game Est. lifetime net (USD) Positive reviews (raw) Release
51 Abduction!?おっぱい星人 $2.9K 70%Positive (27) Jan 23, 2025
52 Sister Lize's suffering $2.7K 62%Mixed (13) Nov 1, 2023
53 Bessie's Milk Delivery $2.5K 91%Positive (22) Sep 7, 2025
54 Infiltrating a Cult $2.5K 58%Mixed (12) Jul 9, 2023
55 Tales of Virginia $2.5K 53%Mixed (17) Oct 11, 2024
56 Prison Break Princess $1.5K 59%Mixed (17) Dec 5, 2024
57 Succubus Melnea $1.1K 45%Mixed (11) Jun 22, 2023
58 Heroes and Test of Succubus 78%Positive (9) Mar 29, 2024
59 Tale of Elisha, Hypnotized Sorcerer 67%Mixed (6) Jun 20, 2025
60 パトラとエロトラップダンジョン (0)

Get real-time dashboards, historical trends, and AI-powered analysis

Explore on PlayRev(opens in new tab)

Revenue and sales estimates are based on the Boxleiter method using publicly available data including Steam review counts, pricing history, and statistical modeling. Actual revenue may differ significantly. These figures are provided for informational purposes only and should not be used for financial decisions. Read the full methodology.